期刊文献+

雷帕霉素缓释微球治疗干燥综合征性干眼的疗效评估 被引量:4

Effect assessment of subconjunctival injection of rapamycin-loaded microspheres in non-obese diabetic mice with dry eye caused by Sjgren's syndrome
下载PDF
导出
摘要 目的:观察结膜下注射新型免疫抑制剂雷帕霉素缓释微球对NOD小鼠干燥综合征(Sjgren's syndrome,SS)性干眼临床体征的改善。方法:SS性干眼的8周龄雌性NOD模型小鼠20只,随机分为4组,每组5只,9周龄时开始给药。另有5只8周龄健康KM小鼠作为正常对照组。实验Ⅰ组和Ⅱ组小鼠分别给予200μg/kg和400μg/kg的雷帕霉素缓释微球结膜下注射,实验Ⅲ组和Ⅳ组动物分别给予生理盐水和空白微球载体结膜下注射。用药前及用药后第5,10,15,20d检查各组小鼠的泪液分泌量,对角膜行荧光素染色并评分,对角结膜行虎红染色并评分,用结膜印记细胞学方法检测结膜细胞并分级。结果:实验组与对照组相比,泪液分泌量明显增加,角膜荧光素染色和角结膜虎红染色评分降低,结膜印记细胞学等级降低。结论:雷帕霉素缓释微球可以通过抑制细胞免疫反应,增加NOD小鼠泪液分泌量,对NOD小鼠干燥综合征性干眼具有显著疗效。 AIM: To study the effect of rapamycinloaded microspheres in non-obese diabetic (NOD) mice with dry eye caused by SjSgren's syndrome( SS). METHODS: Twenty 8-week-old female NOD mice with dry eye caused by SS were randomly divided into 4 groups. One week later, the mice were treated with subconjunctival injection. Group I and II received 2001J g/kg and 400tJg/kg rapamycin-loaded microspheres, Group Ill and IV received normal saline and empty microspheres. Five 8-week-old female healthy KM mice were used as untreated controls. Before and 5, 10, 15, 20 days after the experiment, the amount of secretion of tears, the score of corneal fluorescein staining and rose bengal staining were investigated. Conjunctival epithelial cells were observed and graded by conjunctival impression cytology. RESULTS: Compared with the group III and IV, the amount of secretion of tears of the mice in group I and II increased. The scores of corneal fluorescein staining androse bengal staining were lower. The levels of conjunctival impression cytology reduced. CONCLUSION: Rapamycinloaded microspheres can decrease dry eye signs by alleviating the ocular surface inflammation of NOD mice. It suggests rapamycin-loaded microsphere is valuable to dry eye caused by SS.
作者 王梦 刘焰
出处 《国际眼科杂志》 CAS 2013年第5期861-864,共4页 International Eye Science
基金 上海市临床医学中心项目(No.QY040101) 上海市卫生局科研课题(No.2008164)~~
关键词 雷帕霉素 微球 NOD小鼠 干燥综合征 干眼 rapamycin microsphere non-obese diabeticmice Sjogren's syndrome dry eye
  • 相关文献

参考文献16

  • 1Smith JA. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf2007 ;5(2) :93-107.
  • 2Lemp MA, Baudouin C, Baum J, et al. The definition and classification of dry eye disease : report of the definition and classification subcommittee of the international dry eye workshop (2007). Ocul Surf2007 ;5 (2) :75-92.
  • 3干燥综合征诊治指南(草案)[J].中华风湿病学杂志,2003,7(7):446-448. 被引量:186
  • 4Chang JY, Selgal SN. Plaramacology of rapamycin: a immunosuppressive agent. Br J Rheumatol 1991 ;30 (2) :62-65.
  • 5Kitagawa H, Hotta Y, Fujiki K, et al. Cloning and high expression of rabbit FKBP25 in cornea. Jpn J Ophthalmol 1996;40(2) :133-141.
  • 6王莎莎,刘焰,胡道德.球结膜下注射用西罗莫司缓释微球的制备及其体外释药性能[J].中国新药与临床杂志,2012,31(6):312-317. 被引量:4
  • 7Nakamura S, Shibuya M, Nakashima H, et al. D-β-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board, lnvest Ophthalrnol Vis Sci 2005 ;46(7) :2379-2387.
  • 8Van Bijsterveld OP. Diagnostic tests in sicea syndrome. Arch Ophthalmol 1969;82(1 ) :10-14.
  • 9Nelson JD. Impression cytology. Cornea 1988 ;7(1) :71.
  • 10Yanagi K, Ishimaru N, Haneji N, et al. Anti - 120 - Kdaα - fodrin immune response with Th 1-cytokine profile in the NOD mouse model of Sjogren's syndrome. Eur J lmmounol 1998:28 (10) ,3336-3345.

二级参考文献35

  • 1KAHAN BD, CAMARDO JS. Rapamycin: clinical results and future opportunities[J]. Transplantation, 2001, 72 (7) : 1181- 1193.
  • 2BERTELMANN E, PLEYER U. Immunomodulatory therapy in ophthalmology-is there a place for topical application[J]. Ophthal- mologica, 2004, 218(6): 359-367.
  • 3MARTI HP, FREY FJ. Nephrotoxicity of rapamycin: an emer- ging problem in clinical medicine[J]. Nephrol Dialysis Transplant, 2005, 20( 1 ) : 13-15.
  • 4BIRNBAUM F, REIS A, BOHRINGER D, et al. An open prospective pilot study on the use of rapamycin 'after penetrating high-risk keratoplasty[J]. Transplantation, 2006, 81(5).. 767- 772.
  • 5YUAN XB, YUAN YB, JIANG W, et al. Preparation of rapamycin-loaded chitosan/PLA nanoparticles for immunosup- pression in corneal transplantation[J]. Int J Pharm, 2008, 349 (1-2) : 241-248.
  • 6SHI WY, GAO H, XIE LX. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits[J]. Invest Ophthalmol Vis Sci, 2006, 47(8): 3339-3344.
  • 7LIONZO MI, GUTERRE RS, POHLMANN AR. Microparticles prepared with poly (hydroxybutyrate-eo-hydroxyvalerate) and poly (-caprolactone) blends to control the release of a drug model[J]. J Microencapsulation, 2007, 24(2): 175-186.
  • 8KWOM YS, HONG HS, KIM JC, et al. Inhibitory effect of rapamyein on corneal neovascularization in vitro and in vivo [J]. Invest Ophthalmol Vis Sci, 2005, 46(2) : 454-460.
  • 9CHANG JY, SEHGAL SN. Phrrnacology of rapamycin: a new immunosupressive agent[J]. Br J Rheumatol, 1991, 30 Suppl 2: 62-65.
  • 10KITAGAWA H, HOTTA Y, FUJIKI K, et al. Cloning and high expression of rabbit FKBP25 in cornea [J]. Jpn J Ophthalmol, 1996, 40(2) : 133-141.

共引文献206

同被引文献51

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部